D-Index & Metrics Best Publications

Nigel H. Russell

University of Nottingham
United Kingdom

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 89 Citations 28,409 583 World Ranking 8026 National Ranking 776

Overview

What is he best known for?

The fields of study Nigel H. Russell is best known for:

Bacteria
Enzyme
Quantum mechanics

In his research, Nigel H. Russell undertakes multidisciplinary study on Biochemistry and Biophysics. His work often combines Biophysics and Biochemistry studies. His work on Candida albicans expands to the thematically related Microbiology. His Microbiology research extends to the thematically linked field of Candida albicans. His work on Membrane is being expanded to include thematically relevant topics such as Lysophosphatidylcholine. His Lysophosphatidylcholine study frequently links to related topics such as Membrane. He undertakes interdisciplinary study in the fields of Bacteria and Food poisoning through his works. Nigel H. Russell merges many fields, such as Food poisoning and Salmonella, in his writings. He performs multidisciplinary study on Salmonella and Listeria monocytogenes in his works.

His most cited work include:

Cold adaptation of microorganisms (330 citations)
Toward a molecular understanding of cold activity of enzymes from psychrophiles (272 citations)
Membranes as a target for stress adaptation (257 citations)

What are the main themes of his work throughout his whole career to date

Nigel H. Russell performs integrative study on Biochemistry and Chromatography. Bacteria and Enzyme are two areas of study in which Nigel H. Russell engages in interdisciplinary work. Nigel H. Russell combines Enzyme and Bacteria in his studies. In his works, he performs multidisciplinary study on Genetics and Microbiology. In his research, he performs multidisciplinary study on Microbiology and Genetics. Nigel H. Russell performs integrative study on Organic chemistry and Biochemistry. His Membrane study typically links adjacent topics like Phosphatidylglycerol. He carries out multidisciplinary research, doing studies in Phosphatidylglycerol and Phosphatidylcholine. Phosphatidylcholine and Phospholipid are two areas of study in which he engages in interdisciplinary research.

Nigel H. Russell most often published in these fields:

Biochemistry (50.77%)
Bacteria (41.54%)
Genetics (41.54%)

What were the highlights of his more recent work (between 2008-2021)?

Internal medicine (60.00%)
Nemaline myopathy (20.00%)
Cardiology (20.00%)

In recent works Nigel H. Russell was focusing on the following fields of study:

Nigel H. Russell regularly ties together related areas like Lethargy in his Internal medicine studies. His research is interdisciplinary, bridging the disciplines of Internal medicine and Lethargy. His Nemaline myopathy study frequently draws parallels with other fields, such as Pathology. Many of his studies on Pathology involve topics that are commonly interrelated, such as Myopathy. In his work, he performs multidisciplinary research in Myopathy and Nemaline myopathy. Many of his studies involve connections with topics such as Myocarditis and Cardiology. Myocarditis and Cardiology are commonly linked in his work. He conducts interdisciplinary study in the fields of Quaternary and Paleontology through his works. Nigel H. Russell combines Paleontology and Quaternary in his studies.

Between 2008 and 2021, his most popular works were:

Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review (117 citations)
Time scales for dynamical relaxation to the Born rule (95 citations)
A comparison of single-grain and small aliquot dating of fine sand from Cyrenaica, northern Libya (12 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

Charles L. Sawyers;Andreas Hochhaus;Eric Feldman;John M. Goldman.
Blood (2002)

1684 Citations

Assessment of Minimal Residual Disease in Standard-Risk AML.

Adam Ivey;Robert Kerrin Hills;Michael A. Simpson;Jelena V. Jovanovic.
The New England Journal of Medicine (2016)

685 Citations

Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

Alan Kenneth Burnett;Robert Kerrin Hills;Donald Milligan;Lars Kjeldsen.
Journal of Clinical Oncology (2011)

674 Citations

Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)

Norbert Schmitz;Peter Dreger;Meinolf Suttorp;Ernst B. Rohwedder.
Blood (1995)

605 Citations

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

Stephen P. Robinson;Anthony H. Goldstone;Stephen Mackinnon;Angelo Carella.
Blood (2002)

553 Citations

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

Brian A. Walker;Eileen M. Boyle;Christopher P. Wardell;Alex Murison.
Journal of Clinical Oncology (2015)

508 Citations

Targeting FLT3 mutations in AML: review of current knowledge and evidence.

Naval Daver;Richard F. Schlenk;Nigel H. Russell;Mark J. Levis.
Leukemia (2019)

494 Citations

Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres.

G. Gahrton;H. Svensson;M. Cavo;J. Apperley.
British Journal of Haematology (2001)

464 Citations

The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis.

Gareth J. Morgan;Walter M. Gregory;Faith E. Davies;Sue E. Bell.
Blood (2012)

439 Citations

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.

Alan K Burnett;Nigel H Russell;Robert Kerrin Hills;David Bowen.
Lancet Oncology (2015)

416 Citations

If you think any of the details on this page are incorrect, let us know.